210 related articles for article (PubMed ID: 22248473)
1. The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.
Wangpaichitr M; Sullivan EJ; Theodoropoulos G; Wu C; You M; Feun LG; Lampidis TJ; Kuo MT; Savaraj N
Mol Cancer Ther; 2012 Mar; 11(3):604-15. PubMed ID: 22248473
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin resistance in human cervical, ovarian and lung cancer cells.
Chen J; Solomides C; Parekh H; Simpkins F; Simpkins H
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1217-27. PubMed ID: 25894720
[TBL] [Abstract][Full Text] [Related]
3. Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
You BR; Park WH
Mol Carcinog; 2017 Dec; 56(12):2566-2577. PubMed ID: 28667779
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulation of Thioredoxin1 Is Involved in Death of Calu-6 Lung Cancer Cells Treated With Suberoyl Bishydroxamic Acid.
You BR; Park WH
J Cell Biochem; 2016 May; 117(5):1250-61. PubMed ID: 26460805
[TBL] [Abstract][Full Text] [Related]
5. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Wangpaichitr M; Wu C; Li YY; Nguyen DJM; Kandemir H; Shah S; Chen S; Feun LG; Prince JS; Kuo MT; Savaraj N
Oncotarget; 2017 Jul; 8(30):49275-49292. PubMed ID: 28525376
[TBL] [Abstract][Full Text] [Related]
6. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Bhatia M; Tonissen KF
Oncotarget; 2015 Jun; 6(17):15410-24. PubMed ID: 25945832
[TBL] [Abstract][Full Text] [Related]
8. Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
Chen J; Adikari M; Pallai R; Parekh HK; Simpkins H
Cancer Chemother Pharmacol; 2008 May; 61(6):979-87. PubMed ID: 17661040
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species, glutathione, and thioredoxin influence suberoyl bishydroxamic acid-induced apoptosis in A549 lung cancer cells.
You BR; Kim SH; Park WH
Tumour Biol; 2015 May; 36(5):3429-39. PubMed ID: 25537089
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
11. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
[TBL] [Abstract][Full Text] [Related]
12. Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death.
Tian C; Gao P; Zheng Y; Yue W; Wang X; Jin H; Chen Q
Cell Res; 2008 Apr; 18(4):458-71. PubMed ID: 18157160
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer.
Samaranayake GJ; Troccoli CI; Huynh M; Lyles RDZ; Kage K; Win A; Lakshmanan V; Kwon D; Ban Y; Chen SX; Zarco ER; Jorda M; Burnstein KL; Rai P
Nat Commun; 2017 Oct; 8(1):1204. PubMed ID: 29089489
[TBL] [Abstract][Full Text] [Related]
14. Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels.
You BR; Park WH
Int J Oncol; 2014 May; 44(5):1745-55. PubMed ID: 24626405
[TBL] [Abstract][Full Text] [Related]
15. Role of thioredoxin 1 and thioredoxin 2 on proliferation of human adipose tissue-derived mesenchymal stem cells.
Song JS; Cho HH; Lee BJ; Bae YC; Jung JS
Stem Cells Dev; 2011 Sep; 20(9):1529-37. PubMed ID: 21158569
[TBL] [Abstract][Full Text] [Related]
16. Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells.
Kim MC; Hwang SH; Yang Y; Kim NY; Kim Y
Neoplasia; 2021 Jul; 23(7):653-662. PubMed ID: 34134082
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
[TBL] [Abstract][Full Text] [Related]
18. MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma.
Kong LR; Chua KN; Sim WJ; Ng HC; Bi C; Ho J; Nga ME; Pang YH; Ong WR; Soo RA; Huynh H; Chng WJ; Thiery JP; Goh BC
Mol Cancer Ther; 2015 Jul; 14(7):1750-60. PubMed ID: 25939760
[TBL] [Abstract][Full Text] [Related]
19. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin.
Lu Y; Cederbaum A
Free Radic Biol Med; 2007 Oct; 43(7):1061-75. PubMed ID: 17761302
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
